2nd Quarter - Report
GILBERT'S LLP for MYLAN LABORATORIES INC
Firm
Client
Income
$75,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Consumer Issues/Safety/Products CSP
Reform to legislation and regulations affecting pharmaceutical drug approval and marketing
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIM GILBERT | — |
| NATHANIEL BRANDON LIPKUS | — |
| JOCELYN MACKIE | — |
Pharmacy PHA
Reform to legislation and regulations affecting pharmaceutical drug approval and marketing
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIM GILBERT | — |
| NATHANIEL BRANDON LIPKUS | — |
| JOCELYN MACKIE | — |
Health Issues HCR
Reform to legislation and regulations affecting pharmaceutical drug approval and marketing
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIM GILBERT | — |
| NATHANIEL BRANDON LIPKUS | — |
| JOCELYN MACKIE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.